Interleukin-10 reduces the endotoxin-induced hyperalgesia in mice

Journal of Neuroimmunology

Volumn 86, Issue 2, 1998, Pages 142-150

  Kanaan, Salim A ^a   Poole, Stephen ^b   Saadé, Nayef E ^a   Jabbur, Suhayl ^a   Safieh Garabedian, Bared ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Hyperalgesia; IL 1 ; IL 10; Inflammation; NGF; TNF

Indexed keywords

ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; DOWN REGULATION; HYPERALGESIA; INFLAMMATION; MALE; MOUSE; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL;

ANIMALS; ENDOTOXINS; HEAT; HINDLIMB; HYPERALGESIA; INTERLEUKIN-1; INTERLEUKIN-10; MALE; MICE; MICE, INBRED BALB C; NERVE GROWTH FACTORS; NOCICEPTORS; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 17544398785     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00027-7     Document Type: Article

References (49)

1. Aiura K., Gelfand J.A., Burke J.F., Thompson R.C., Dinarello C.A. Interleukin-1 receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1β in rabbits. Infect. Immun. 61:1993;3342-3350.
2. Barde Y.-A. Trophic factors and neuronal survival. Neuron. 2:1989;1525-1534.
3. Bencics A., Elenkov I.J., Vizi E.S. Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-alpha production in vivo: involvement of the sympathetic nervous system. J. Neuroimmunol. 73:1997;1-6.
4. Bluthe R.M., Pawlowshi M., Suarez S., Parnet P., Pittman Q., Kelley K.W., Dantzer R. Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinology. 19:1994;197-207.
5. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by Interleukin-10. J. Exp. Med. 174:1991;1549-1555.
6. Bogdan C., Paik J., Vodovotz Y., Nathan C. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and Interleukin-10. J. Biol. Chem. 267:1992;23301-23308.
7. Carman-Krzan M., Vige X., Bradley W. Regulation by Interleukin-1 of nerve growth factor secretion and nerve growth factor mRNA expression in rat primary astroglial cultures. J. Neurochem. 56:1991;636-643.
8. Crofford L.J. COX-1 and COX-2 tissue expression: implications and predictions. J. Rheumatol. 24:1997;15-19.
9. Cunha F.Q., Poole S., Lorenzetti B.B., Ferreira S.H. The pivotal role of tumor necrosis factor α in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 107:1992;660-664.
10. de Waal Malefyt R., Abrams J., Bennett B., Figdor C., De Vries J. IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1991;1209-1220.
11. de Waal Malefyt R., Yssel H., Roncarolo M.G., Spits H., De Vries J. Interleukin-10. Curr. Opin. Immunol. 4:1992;314-320.
12. de Waal Malefyt R., Figdor C.G., Huijbens R., Mohan-Peterson S., Bennett B., Culpepper J., Dang W., Zurawski G., de Vries J.E. Effect of IL-13 on phenotype, cytokine production and cytotoxic function of human monocytes: comparison with IL-4 and modulation by Ifn-γ or IL-10. J. Immunol. 151:1993;6370-6381.
13. Donnerer J., Schuligoi R., Stein C. Increased content and transport of substance P and calcitonin gene related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience. 49:1992;693-698.
14. Fantuzzi G., Zheng H., Faggioni R., Benigni F., Ghezzi P., Sipe J., Shaw A., Dinarello C.A. Effect of endotoxin in Il-1β-deficient mice. J. Immunol. 157:1996;291-296.
15. Ferreira S.H., Lorenzetti B.B., Poole S. Bradykinin initiates cytokine mediated inflammatory hyperalgesia. Br. J. Pharmacol. 110:1993;1227-1231.
16. Fiorentino D.F., Zlotnik A., Mossmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:1991;3815-3822.
17. Friedman W.J., Larkafors L., Ayer-Lelievre C., Ebendal T., Olsson L., Persson H. Regulation of nerve growth factor expression by inflammatory mediators in hippocampal cultures. J. Neurosci. Res. 27:1990;374-382.
18. Gadient R.A., Cron K.C., Otten U. Interleukin-1 and tumor necrosis factor-synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci. Lett. 117:1990;335-340.
19. Gazinelli R.T., Oswald I.P., James S.L., Sher A. IL-10 inhibits parasite killing and nitric oxide production by IFN-γ activated macrophages. J. Immunol. 148:1992;1792-1796.
20. Hattori A., Tanaka E., Murase K., Ishida N., Chatani Y., Tsujimoto M., Hayashi K., Kohno M. Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells. J. Biol. Chem. 268:1993;2577-2582.
21. Herbert J.M., Savi P., Laplace M.C., Lale A., Dol F., Duams A., Labit C., Minty A. IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS. 328:1993;268-270.
22. Howard M., O'Garra A., Ishida H., de Waal Malefyt R., De Vries J. Biological properties of IL-10. J. Clin. Immunol. 12:1992;239-247.
23. Howard M., Muchamuel T., Andrade S., Menon S. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1993;1205-1208.
24. Johnson E.M., Rich K.M., Yip H.K. The role of NGF in sensory neurons in vivo. Trends Neurosci. 9:1986;33-37.
25. Kanaan S.A., Saadé N.E., Haddad J.J., Abdelnoor A.M., Atweh S.F., Jabbur S.J., Safieh-Garabedian B. Endotoxin-induced local inflammation and hyperalgesia in rats and mice: a new model for inflammatory pain. Pain. 66:1996;373-379.
26. Kanaan S.A., Safieh-Garabedian B., Haddad J.J., Atweh S.F., Abdelnoor A.M., Saadé N.E., Jabbur S.J. Effects of various analgesic and anti-inflammatory drugs on endotoxin-induced hyperalgesia in rats and mice. Pharmacol. 54:1997;285-297.
27. Korsching S. The neurotrophic factor concept: a re-examination. J. Neurosci. 13:1993;2739-2748.
28. Lindholm D., Neumann R., Meyer M., Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of sciatic nerve. Nature. 330:1987;658-659.
29. Marie C., Pitton C., Fitting C., Cavaillon J.M. IL-10 and IL-4 synergize with TNF-α to induce IL-1ra production by human neutrophils. Cytokine. 8(2):1996;147-151.
30. Marie C., Pitton C., Fitting C., Cavaillon J.M. Regulation by anti-inflammatory cytokines (IL-4, IL-10, IL-13, TGFβ) of interleukin-8 production by LPS-and/or TNFα-activated human polymorphonuclear cells. Med. Inflam. 5:1996;334-340.
31. Matsuoka I., Meyer M., Thoenen H. Cell type specificity regulation of nerve growth fact or (NGF) synthesis in non-neuronal cells: comparison of Schwann cells with other cell types. J. Neurosci. 11:1991;3165-3177.
32. Mertz P.M., DeWitt D.L., Stetler-Stevenson W.G., Wahl L.M. Interleukin 10 suppression of monocyte prostaglandin H synthase. 2: Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J. Biol. Chem. 269:1994;21322-21329.
33. Moore K.W., O'Garra A., De Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 11:1993;165-190.
34. Niiro H., Otsuka T., Tanabe T., Hara S., Kuga S., Memoto Y., Tanaka Y., Nakashima H., Kitajima S., Abe M., Niho Y. Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: its underlying mechanism in comparison with interleukin-4. Blood. 85:1995;3736-3745.
35. Oswald I.P., Wynn T.A., Sher A., James S.L. Interleukin-10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor α required as a costimulatory factor for interferon γ-induced activation. Proc. Natl. Acad. Sci. U.S.A. 89:1992;8676-8680.
36. Poole S., Cunha F.Q., Selnik S., Lorenzetti B.B., Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br. J. Pharmacol. 115:1995;684-688.
37. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.J. Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br. J. Pharmacol. 115:1995;1265-1275.
38. Safieh-Garabedian B., Poole S., Allchorne A., Kanaan S., Saadé N., Woolf C. Zinc reduces the hyperalgesia and upregulation of NGF and IL-1β produced by peripheral inflammation in the rat. Neuropharmacol. 35:1996;509-603.
39. 2 in endotoxin induced localized inflammatory hyperalgesia. Br. J. Pharmacol. 121:1997;1619-1626.
40. Spranger M., Lindholm D., Bandtlow C., Heumann R., Gnahn H., Naher-Noe M., Thoenen H. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur. J. Neurosci. 2:1990;69-76.
41. Taktak Y.S., Selkirk S., Bristow A.F., Carpenter A., Ball C., Rafferty B., Poole S. Assay of pyrogens by Interleukin-6 release from monocyte cell lines. J. Pharm. Pharmacol. 43:1991;578-582.
42. Tripp C.S., Beckerman K.P., Unanue E.R. Immune complexes inhibit antimicrobial responses through Interleukin-10 production. J. Clin. Invest. 95:1995;1628-1634.
43. Van der Poll T., Jansen P.M., Montegut W.J., Braxton C.C., Calvano S.E., Stackpole S.A., Smith S.R., Swanson S.W., Hack C.E., Lowry S.F., Moldawer L.L. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J. Immunol. 158:1997;1971-1975.
44. Watkins L.R., Wiertelak E.P., Goehler L., Smith K.P., Martin D., Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res. 654:1994;15-26.
45. Watkins L., Maier S., Goehler L. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 63:1995;289-302.
46. Weskamp G., Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J. Neurochem. 48:1987;1779-1786.
47. Woolf C.J., Safieh-Garabedian B., Ma Q.-P., Crilly P., Winter J. Nerve growth factor contributes to the generation of inflammatory hypersensitivity. Neuroscience. 62:1994;327-331.
48. Woolf C.J., Allchorne A., Safieh-Garabedian B., Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumor necrosis factor α Br. J. Pharmacol. 121:1997;417-424.
49. Zimmerman M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.